About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, May 23rd, 2014

The QualityStocks
Daily Stock List


GreenShift Corp. (GERS)

PennyStocks24 and StockMister reported earlier on GreenShift Corp. (GERS), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Based in Alpharetta, Georgia, GreenShift Corp. develops and commercializes clean technologies. The design of these is to address the financial and environmental requirements of its clients through decreasing raw material needs, facilitating co-product reuse, and reducing the generation of wastes and emissions. GreenShift develops and commercializes clean technologies that facilitate the more efficient use of natural resources. GreenShift lists on the OTC Markets’ OTCQB.  

The Company is concentrating on developing and commercializing clean technologies in the U.S. ethanol industry. GreenShift, in this industry, innovates and offers technologies that improve the profitability of licensed ethanol producers. Its wholly-owned subsidiary is GS CleanTech Corp.

GreenShift invented, developed, commercialized and patented new technologies that integrate into the back-end of existing dry mill corn ethanol plants to tap into a new reserve of inedible crude corn oil. This corn oil is a valuable feedstock for use in the production of advanced carbon-neutral liquid fuels and other biomass-derived alternatives to fossil fuel-based products.

GreenShift’s corn oil extraction technologies increase corn-to-biofuel yields. They do so while reducing the energy and greenhouse gas intensity of corn ethanol production for dry mill ethanol producers. The Company’s first corn oil extraction patent was issued in October 2009. GreenShift continues to defend against all infringements of its corn oil extraction patents to protect the competitive advantage of its licensed ethanol plants.  

Regarding Research and Development, the Company’s patent-pending Cellulosic Oil™ process conditions and converts the residual sugars, starch, and cellulosic biomass in distillers’ grain and selected offsite biomass into increased oil and protein yield. Pertaining to Feedstock Conditioning, GreenShift’s patented Tornado Generator™ accelerates compressed air to supersonic speeds to almost immediately grind, flash desiccate, atomize, and homogenize solids and liquids into micron sized powders. 

Concerning the Algae Bioreactor, GreenShift holds the exclusive rights to this patented process, which utilizes thermophillic cyanobacteria to consume carbon dioxide emissions. The organisms use the available carbon dioxide in the emissions and water to grow and give off oxygen and water vapor.

Last week, the GS CleanTech subsidiary announced it extended its on-going service contract with Sunoco, Inc. through the end of 2016. The contract calls for GS CleanTech to provide maintenance and corn oil yield enhancements for the Corn Oil Extraction System licensed to Sunoco at its Fulton ethanol plant.

GreenShift Corp. (GERS), closed Friday's trading session at $0.0289, up 15.60%, on 391,454 volume with 42 trades. The average volume for the last 60 days is 82,403 and the stock's 52-week low/high is $0.01/$0.29.

SPO Global, Inc. (SPOM)

PennyStocks24 reported earlier on SPO Global, Inc. (SPOM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SPO Global, Inc. is a leading developer of biosensor and microprocessor technologies for use in portable wellness devices. The Company’s patented technology uses information gathered from the reflectance of light on the human body, in a non-invasive way, to monitor important vital signs. SPO Global manufactures its products in addition to licensing its technologies to appropriate client corporations for commercialization and distribution. SPO Global’s shares trade on the OTCQB.

The Company’s operating divisions are SPO Wellness for consumer related wellness applications; SPO Medical for medical related oximetry products; SPO Baby for consumer related baby monitoring, and SPO Security for safety and surveillance applications.

SPO Global technology is in pulse oximetry. This is a vital non-invasive process used to measure blood oxygen saturation levels (SpO2) by monitoring the percentage of hemoglobin (Hb), which is saturated with oxygen and measuring heart rate. SPO Global developed patented sensors that work accurately during physical activity. This technique uses a reflectance method where a very small sensor placed on the body at different locations can measure oxygen saturation and heart pulse rate. The Company has patented the technology that uses the reflectance technique and incorporates it into portable devices for an array of medical and non-medical applications. 

In April, SPO Global announced financial results for the year ended December 31, 2013. During this period it expanded its new wellness product line and increased sales activities. Total revenue for 2013 was $556,000 versus $316,000 for the same period in 2012. The increase in revenue is mainly attributable to the expanded distribution of its private-labeled pulse oximeter - the HoMedics Deluxe Pulse Oximeter - for Over-The-Counter (OTC) consumer wellness markets.

Furthermore, during Q4-2013 SPO Global, by way of its partnership with MZB & Company, Inc., launched a new consumer wellness watch that incorporates unique wearable technology branded as "Live Well by SHARP" designed to measure overall daily activity level. The product continuously measures the number of daily activities and calories burned against a recommended goal.

SPO Global, Inc. (SPOM), closed Friday's trading session at $0.0192, even for the day. The average volume for the last 60 days is 46,249 and the stock's 52-week low/high is $0.011/$0.296.

INVENT Ventures, Inc. (IDEA)

Today we are reporting on INVENT Ventures, Inc. (IDEA), here at the QualityStocks Daily Newsletter.

INVENT Ventures, Inc. is a technology venture fund whose shares trade on the OTC Markets’ OTCQB. The Company builds, manages, and invests in early-stage web and mobile technology companies. It supplies portfolio companies with the capital to nurture its initial product, and provides practical support services to decrease start-up costs and speed up time to market.  INVENT Ventures has its headquarters in Santa Monica, California.

The Company develops businesses in the consumer Internet, mobile and biotechnology markets. INVENT owns six companies at different stages of development. Its services include product development and design, corporate formation and structure, as well as exposure to additional financing.

INVENT Ventures builds initial prototypes, crafts teams around each idea, and provides access to capital. The Company’s process maximizes efficiencies in how companies are conceived, built, and brought to market. INVENT’s structure provides all of its stakeholders with access to early stage venture capital by way of its curated and actively managed portfolio of technology businesses.

Last week, INVENT Ventures announced that its portfolio company Stockr, Inc. received an investment from STAR Angel Network. Stockr is a modern social network. It connects investors to each other, to investor relations departments at public companies, and to industry experts. STAR Angel Network is a New York, New York-based Angel network consisting of professional athletes and business leaders. Stockr provides a specialized platform where investors, analysts, and public companies can communicate transparently and directly regarding financial news, stocks, market trends, investment ideas, and more. 

This week, INVENT Ventures announced that its portfolio company Sanguine Biosciences, Inc. secured an agreement with Mayo Clinic Bioservices. With this agreement, Mayo Clinic Bioservices will process, store and ship biospecimens collected by Sanguine Biosciences for the purpose of developing new therapies. Mayo Clinic Bioservices will provide integrated laboratory services. This includes specimen accessioning, processing, nucleic acid extraction, specimen tracking, storage and shipping.

INVENT Ventures, Inc. (IDEA), closed Friday's trading session at $0.295, up 1.72%, on 376,648 volume with 149 trades. The average volume for the last 60 days is 45,015 and the stock's 52-week low/high is $0.12/$0.348.

Eventure Interactive, Inc. (EVTI)

SmallCapReview reported earlier on Eventure Interactive, Inc. (EVTI), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Trading on the OTC Bulletin Board, Eventure Interactive, Inc. is a social application development enterprise. The Company captures everyday events and turns them into meaningful memories to be scrapbooked, organized, and referenced forever - automatically. At Eventure, users can find a web-to-mobile application where individuals can easily create, capture, and organize life's memories. The Company formerly went by the name Live Event Media, Inc. It changed its name to Eventure Interactive, Inc. in February 2013. Founded in 2010, Eventure Interactive is headquartered in Costa Mesa, California.

The Company allows everyone to participate during the planning of an event, easily check-in when they arrive at the event, capture and stream pictures and video during the event, and then scrapboard the collection of activity after it is all complete. Eventure Interactive has established an Events Database consisting of over 20 Million Places and 8 Million Local Events Listings to serve as a valued resource to users when researching, planning, and scheduling their events.

Inside of the Company’s platform, one may either create rich invitations to/from events, and socialize those invitations with friends via direct connection, email, or SMS, or browse future events that friends are attending and opt-in to get invited to join through a private grouping. From there, the native calendar marks the event date, time, and location through synchronizing core calendars (Outlook, Gmail, Yahoo Mail, and iCal); provides astute RSVP management; offers lists for organizing the event, and gives intuitive reminders to event attendees.

Eventure Interactive announced this past March that it reached another execution milestone with the launch of its Creative Library platform. This platform consists of a portfolio of digital invitations, cards, envelopes, stamps, liners, and postmarks providing Eventure users with thousands of combinations to enhance their event planning experience. The Company’s Creative Library is a central feature of its social calendar, which allows users to send professionally designed invitations for their social and business events.

This month, Eventure Interactive announced its inclusion in California-based Orange County Business Journal's annual list of Top 100 Public Companies List. The Annual List ranks companies based on their overall market capitalization. Eventure came in at #71 on the list.

Eventure Interactive, Inc. (EVTI), closed Friday's trading session at $2.51, down 6.69%, on 2,715 volume with 14 trades. The average volume for the last 60 days is 4,504 and the stock's 52-week low/high is $2.00/$3.60.

Bitcoin Shop, Inc. (BTCS)

TheMicrocapNews reported recently on Bitcoin Shop, Inc. (BTCS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bitcoin Shop, Inc. operates an ecommerce website at www.bitcoinshop.us. On this site, consumers can purchase products using virtual currency including bitcoin, litecoin and dogecoin, by searching through a selection of more than 400 categories and more than 140,000 items. Bitcoin Shop connects retailers desiring to accept Bitcoin with consumers desiring to spend Bitcoin. The Company’s goal is to be a leading virtual currency marketplace where consumers and sellers of products and services can use any virtual currency to transact business.  Bitcoin Shop’s shares trade on the OTC Markets’ OTCQB. The Company has its corporate headquarters in Arlington, Virginia.

Bitcoin, litecoin and dogecoin are virtual currencies. These currencies use peer-to-peer networks to enable immediate payments. They are all categorized as cryptocurrencies. They use cryptography as a security measure. Bitcoin, litecoin and dogecoin issuances and transactions are carried out collectively by the network, with no central authority. They allow users to make verified transfers.

Bitcoin Shop’s goal is to present a traditional browse and checkout process to its customers. The primary difference being able to pay with virtual currencies at the checkout instead of Fiat Currency.

At the end of April, Bitcoin Shop announced that it purchased litecoinshop.us, dogecoinshop.us and peercoinshop.us. The new domain names will complement the Company’s virtual currency ecommerce platform.

Mr. Charlie Kiser, Bitcoin Shop’s Chief Marketing Officer, said, "We are very pleased to incorporate these domains into our platform. It has always been our strategic plan to not only facilitate ecommerce transactions for bitcoin, but for many cryptocurrencies. After successfully beginning to accept dogecoin and litecoin, we began to evaluate the purchases of highly trafficked domains with dedicated userbases in an effort to enhance our existing domain assets."

This week, Bitcoin Shop announced that it will be a featured presenter at the 3rd Annual Marcum MicroCap Conference on Thursday, May 29, 2014 in New York, New York at the Grand Hyatt Hotel. The annual Marcum MicroCap Conference is a signature showcase for under-followed public companies with under $500 million in market capitalization. Bitcoin Shop‘s presentation by Mr. Charles Allen, CEO, is scheduled to commence at 9:00 a.m. EDT.

Bitcoin Shop, Inc. (BTCS), closed Friday's trading session at $0.1299, up 6.48%, on 751,834 volume with 139 trades. The average volume for the last 60 days is 1,423,082 and the stock's 52-week low/high is $0.121/$5.26.


The QualityStocks
Company Corner


Innocent, Inc. (INCT)

The QualityStocks Daily Newsletter would like to spotlight Innocent, Inc. (INCT). Today, Innocent, Inc. closed trading at $0.015, up 36.36%, on 13,950 volume with 2 trades. The stock’s average daily volume over the past 60 days is 9,021, and its 52-week low/high is $0.0005/$0.092.

Innocent, Inc. (INCT) is a development stage oil and gas exploration and production company focused on developing properties in North America. The company plans to minimize the risk of exploration through development of proved petroleum reserves, and expects to maximize profit through strategic acquisition and liquidation of selected oil and gas properties.

The company specializes in acquiring low risk, high upside properties with substantial exploration potential. Through improvements in oil and gas production technologies, Innocent aims to rapidly increase production levels and generate predictable, sustainable value. The business strategy utilized calls for both 100% acquisitions and joint-ventures to maximize production capacity.

Evergreen Petroleum, a joint venture partner, is working closely with the company to explore oil-bearing formations in Wyoming. Evergreen has conducted and will continue to conduct both regional and local geological studies to define prospects that are worthy of acquiring oil and gas leases. By partnering with industry experts such as Evergreen, Innocent has strategically added extensive technical guidance and field management experience.

Even during challenging times, the world depends on oil & gas exploration and production companies to deliver millions of barrels of oil every day. Increased demand from emerging countries such as China further escalates competition for this precious resource. Backed by an experienced group of professionals, Innocent is well positioned to generate substantial revenues in the short and long term future. Disclaimer

Innocent, Inc. Company Blog

Innocent, Inc. News:

Innocent Inc. Announces Letter to Shareholders

Innocent Inc. Announces New Joint Venture to Explore for Oil and Gas

Innocent, Inc. (INCT) is "One to Watch"

Mabwe Minerals Inc. (MBMI)

The QualityStocks Daily Newsletter would like to spotlight Mabwe Minerals Inc. (MBMI). Today, Mabwe Minerals Inc. closed trading at $0.079, up 31.67%, on 30,140 volume with 6 trades. The stock’s average daily volume over the past 60 days is 29,045, and its 52-week low/high is $0.03/$0.70.

Mabwe Minerals Inc. (MBMI) is a U.S. based natural resources and hard asset company focused on the mining, logistics, and commercial sales of industrial minerals and metals, with a particular emphasis on barite. The company's operations are conducted through its Zimbabwe affiliate, Mabwe Mineral Zimbabwe (Private) Ltd. Transitioning into commercial production, MBMI's company fundamentals are well positioned with virtually no debt and key strategic partnerships in place.

Along with its affiliate, Mabwe Minerals Zimbabwe (Private) Ltd., an indigenous Zimbabwe company, the company owns 100% of the mineral & metal rights to Dodge Mine. The mine will be managed by the company's minority owned partner, WGB Kinsey & Company, Zimbabwe's most experienced mining & construction company representing four generations of Kinsey leadership. Management believes WGB Kinsey & Company has all the necessary equipment and management experience to efficiently perform all the mining operations at Dodge Mine.

The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc. Hydrothermal barite deposits throughout Dodge Mine represent the highest grade of new barite sources to be brought into commercial production in years. A third party oil & gas drilling sector geologist recently confirmed that the multiple barite deposits are considered "World Class" in quality and highly efficient to mine via open pit extraction following the barite veins and salvaging large percentages of barite within the halo zones via jigging systems.

With a continuing worldwide shortage of high-grade barite, Mabwe Minerals is in the right place at the right time. The company's current customer uses barite as a weighting agent in oil & gas drilling applications in the Gulf of Mexico, home to the largest concentration of active rigs in the world. Coupled with the recent massive discovery of oil & gas off the coast of neighboring Mozambique along with new drilling contracts expected in the region, MBMI is in an attractive geographical location to capture the expected demands of this emerging market. Moving from an exploration stage company into commercial barite production, Mabwe Minerals is well positioned to generate significant shareholder returns. Disclaimer

Mabwe Minerals Inc. Company Blog

Mabwe Minerals Inc. News:

Raptor Resources Holdings Issues Update on the Derbyshire Stone Quarry

Raptor Resources Holdings Acquires the Derbyshire Stone Quarry

Raptor Resources Holdings Completes Expansion of the Dodge Mine Mountain Range

P2 Solar, Inc. (PTOS)

The QualityStocks Daily Newsletter would like to spotlight P2 Solar, Inc. (PTOS). Today, P2 Solar, Inc. closed trading at $0.04, up 10.19%, on 82,325 volume with 4 trades. The stock’s average daily volume over the past 60 days is 66,454, and its 52-week low/high is $0.0122/$0.08.

P2 Solar, Inc. (PTOS) participates in the lucrative renewable energy market as a developer of solar photovoltaic (PV) power projects, focusing its initiatives on “sunbelt” areas where sunlight exposure is abundant; renewable energy policies are favorable; public and private sectors are actively seeking to incorporate solar PV into their electricity consumption profiles; and where governments offer attractive subsidies to motivate development.

Acknowledging rising demand for clean energy worldwide, solar PV power’s increasingly competitive edge over grid electricity, and commercial efforts to reduce reliance on greenhouse gas emitting fossil fuels, P2 Solar invests and channels its resources to benefit from these global trends.

The company’s growth strategy centers on management’s aggressive mandate to develop 150 MWp of electricity generating capacity in several phases over the next few years. To this accord, the company is focused on further development of its project portfolio, which currently consists of the Langley Rooftop Project in British Columbia; the Rajgarh Mini-hydro Project in Punjab, India; and the Tibba Mini-hydro Project, also located in Punjab India.

Backed by executive leadership with more than 60 years of combined experience, P2 Solar continues to develop and expand its current projects while opportunistically pursuing development opportunities in other regions with favorable solar energy regimes, including Eastern Europe and Canada. Disclaimer

P2 Solar, Inc. Company Blog

P2 Solar, Inc. News:

P2 Solar Signs Implementation Agreement for Rajgarh Hydro Project

P2 Solar Receives Government Approval for Rajgarh Hydro Project

P2 Solar Acquires Its Second Renewable Energy Project in India

VistaGen Therapeutics, Inc. (VSTA)

The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.70, up 4.48%, on 26,488 volume with 18 trades. The stock’s average daily volume over the past 60 days is 4,765, and its 52-week low/high is $0.25/$0.89.

VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.

VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.

By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve.  According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.

Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months.  VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits.  In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations. 

AV-101, VistaGen's lead small molecule prodrug candidate has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.

Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data.  To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.

VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer

VistaGen Therapeutics, Inc. Company Blog

VistaGen Therapeutics, Inc. News:

VistaGen Joins HESI's Cardiac Safety Committee and Working Groups

VistaGen Receives Notice of Allowance for U.S. Patent Expanding Stem Cell Technology Platform for Drug Rescue and Regenerative Medicine

VistaGen Joins the Cardiac Safety Research Consortium

NeuroMama Ltd. (NEROE)

The QualityStocks Daily Newsletter would like to spotlight NeuroMama Ltd. (NEROE). Today, NeuroMama Ltd. closed trading at $7.00, even for the day. The stock’s average daily volume over the past 60 days is 3, and its 52-week low/high is $5.00/$28.00.

NeuroMama Ltd. (NEROE) utilizes high quality neural technology to provide super-accurate search returns and power a suite of products including a web search engine, mobile app, more than 120 social networks, email service, finance center, kids zone, and more. The company is also developing the Eurasia Resort/Convention, Retail/Sport and Entertainment Complex in Las Vegas, Nevada, and is highly engaged in international multi-language streaming media distribution via TVIMama.com, Xtreme Sports production, and network/cable distribution.

NeuroZone is just one example of the numerous initiatives underway to expand NeuroMama’s brand and influence. This virtual mall will leverage all the promotional, marketing, and technologic power invested in NeuroMama’s entire stable of highly integrated, symbiotically compatible projects and strategic relationships to create the world’s first, and to date only, viable competitor to mega online retailers like Amazon and eBay. NeuroZone will provide unlimited branding opportunities for NeuroMama’s internet platform, products and services.

NeuroMama recently acquired an extensive library of entertainment assets, which includes a variety of shows, feature films, television pilots, and more. Valued at approximately $100 million dollars, this content library can be rented, liscenced and distributed an infinite number of times. The company is currently deploying an advanced, next-generation Internet Content Distribution Platform (CDP) designed to offer e-commerce merchants and entertainment programmers the most secure, fastest, and robust digital delivery system yet developed.

Other Neuromama.com platform products include NeuroMANIA.com, a child-and-parent friendly hub with 120+ social networks themed to professional and personal interests; and TVIMama.com, video-on-demand streaming and broadcasting of live television. Notably, users of the NeuroMama.com all-in-one internet platform now are earning free breathtaking luxury vacations and free magnificent international cruises with the web's premiere frequent searcher/shopper user loyalty program.

NeuroMama’s team of forward-thinking individuals have engineered an all-encompassing platform from the ground up to take maximum advantage of the last decade's advances in Web crawling, data storage and management, content comparison, analysis and sorting. With numerous opportunities to further expand in the booming Internet market, NeuroMama is well positioned to fully capitalize on its advanced neural technology. Disclaimer

NeuroMama Ltd. Company Blog

NeuroMama Ltd. News:

CES Event Showcasing Intelligent Search Engine, Online Retail Platform and Advertising Opportunities, Reception Act Performer Fall and Serious Injuries Documented

NeuroMama, Ltd. 10Q Will Be Filed In Days. Filing Is Late To Preserve $17MM Asset

NeuroMama's Global Enterprises at International CES


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters








By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251